In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma

There are currently no effective treatments for advanced‐stage papillary renal cell carcinoma (PRCC). The goal of this study is to define potential DNA methylation‐based markers and treatment targets for advanced‐stage type 2 PRCC. Progressive DNA methylation changes and copy number variation (CNV)...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Man, Hlady, Ryan A., Zhou, Dan, Ho, Thai H., Robertson, Keith D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745825/
https://www.ncbi.nlm.nih.gov/pubmed/31361072
http://dx.doi.org/10.1002/cam4.2402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745825/
https://www.ncbi.nlm.nih.gov/pubmed/31361072
http://dx.doi.org/10.1002/cam4.2402

Ejemplares similares